Knut Eis
5PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 15, 2025
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer.Franziska Siegel, Stephan Siegel, Kristýna Kotýnková
|Oct 21, 2022
Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069.Douglas L Orsi, Elisabeth Pook, Nico Bräuer
|Aug 24, 2021
BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies.Markus Berger, Lars Wortmann, Philipp Buchgraber
|Jun 06, 2020
Damage Incorporated: Discovery of the Potent, Highly Selective, Orally Available ATR Inhibitor BAY 1895344 with Favorable Pharmacokinetic Properties and Promising Efficacy in Monotherapy and in Combination Treatments in Preclinical Tumor Models.Ulrich Lücking, Lars Wortmann, Antje M Wengner
Pageof 1
Frequent Collaborators
2 joint publications
Ulrich Lücking
2 joint publications
Lars Wortmann
2 joint publications
Markus Berger
2 joint publications
Nico Bräuer
2 joint publications
Anders Friberg
2 joint publications
Jonathan T Goldstein
1 joint publications
Julien Lefranc
1 joint publications
Florian Bartels
1 joint publications
Carl F Nising
1 joint publications
Douglas L Orsi
